LAVA-1207
lava therapeutics
['crpc', 'gu ', '$lvtx', 'lava therap']
lava therapeutics announces initial data from the ongoing phase 1/2a clinical trial of lava-1207 in therapy refractory mcrpc at the 2023 asco gu symposium $lvtx 
Run by investors, for investors.

Real-time:
PRs
Gov. contract awards
Earnings
M&As
FDA approvals
Insider trades
SEC filings
And more

Not investment advice